Starling Oncology, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Starling Oncology, Inc. (DFPH) reported Adjustments to Additional Paid in Capital, Warrant Issued of $1.12 million for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-12-14.
Discontinued › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2021-12-14
- Starling Oncology, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2020-03-31 was $1.12M.
- Starling Oncology, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2020 was $1.12M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 3 month as first filed | Adjustments to Additional Paid in Capital, Warrant Issued 12 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month as first filed |
|---|---|---|---|---|---|
| 2020-12-31 | $1.12M 10-K/A · filed 2021-12-14 | $5.60M 10-K · filed 2021-03-30 | |||
| 2020-03-31 | $1.12M 10-Q/A · filed 2021-12-14 | $5.60M 10-Q · filed 2020-05-08 | |||
| 2020-03-13 | $300.00K 10-K/A · filed 2021-05-24 |